Ventas Heads Into Earnings With Bulls in Control

Short sellers have been less certain. Short interest as a percentage of the float jumped 29% on the week to 4% — a material move in a single week — reversing a steady decline from 5% in late March. Yet borrow conditions tell a different story. Availability remains ample and the cost to borrow is just 0.55%, barely changed over the month. The short-score uptick to 43 from 39.5 a week ago reflects the renewed short positioning, but at current levels it does not signal a crowded or aggressive short thesis. The borrow market is simply not tight enough to suggest a squeeze dynamic is in play.

The bull-bear debate for Ventas centres on reimbursement risk versus portfolio resilience. Bears point to potential Medicare and Medicaid cuts, which could pressure rent coverage at some of the company's healthcare tenants and test the 5%-plus revenue concentration from individual operators. Bulls counter with the breadth of the portfolio — nearly 1,400 properties across senior housing, medical office and international markets — and the EPS momentum picture, which ranks in the 95th percentile on a 90-day basis. Analysts have leaned bullish through March: Wells Fargo and JPMorgan both lifted targets to $93, Mizuho went to $94, and Citi sits at $96 — all maintaining positive ratings. No major firm has cut heading into the print.

The Q1 report is therefore less about the direction of travel and more about whether Ventas's senior housing operating margins and same-store NOI growth can justify a stock that has already priced in much of the upgrade cycle.